Keywords: novartis, tekturna, hct, cleared, fda, swiss, drug

Novartis' Tekturna HCT cleared by FDA

Article | 28 January 2008

Print This

Swiss drug major Novartis says that its blood pressure treatment Tekturna HCT (aliskiren and hydrochlorothiazide) has been approved by the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in